Xuan Zeng Selected Research

Triple Negative Breast Neoplasms

1/2021

Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuan Zeng Research Topics

Disease

63	Neoplasms (Cancer) 04/2024 - 03/2005
10	Breast Neoplasms (Breast Cancer) 10/2022 - 03/2005
6	Lung Neoplasms (Lung Cancer) 10/2022 - 05/2008
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 07/2006
5	Inflammation (Inflammations) 03/2023 - 04/2018
5	Adenocarcinoma of Lung 01/2023 - 07/2010
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
4	Cough 01/2021 - 04/2018
4	Adenocarcinoma 07/2015 - 07/2006
3	Body Weight (Weight, Body) 01/2024 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 07/2007
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 07/2006
3	Disease Resistance 03/2018 - 09/2015
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2010 - 12/2004
2	Hypoxia (Hypoxemia) 03/2024 - 01/2020
2	Starvation 03/2024 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 10/2022 - 01/2017
2	Infections 10/2022 - 03/2018
2	Bacterial Infections (Bacterial Infection) 05/2022 - 01/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 11/2019
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2020 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2020
2	Lymphatic Metastasis 01/2020 - 03/2017
2	Adrenocortical Adenoma (Disease, Conn's) 01/2014 - 11/2011
2	Chronic Pancreatitis 11/2010 - 02/2007
2	Carcinoma (Carcinomatosis) 12/2008 - 07/2006
1	Atherosclerosis 01/2024
1	Atherosclerotic Plaque (Atheroma) 01/2024
1	Myocardial Infarction 12/2023

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2005
17	ParaffinIBA 01/2020 - 12/2004
10	Formaldehyde (Formol)FDA Link 01/2020 - 07/2006
9	ErbB Receptors (EGF Receptor)IBA 06/2019 - 07/2006
8	Peptides (Polypeptides)IBA 01/2020 - 01/2013
7	Silicon Dioxide (Silica)FDA LinkGeneric 10/2022 - 05/2015
6	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 02/2016
5	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 02/2007
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 08/2009
4	Oxygen (Dioxygen)IBA 03/2024 - 01/2019
4	Therapeutic UsesIBA 01/2022 - 01/2020
4	Metal-Organic FrameworksIBA 01/2021 - 01/2018
4	Immune Checkpoint InhibitorsIBA 01/2021 - 06/2019
4	Capsules (Microcapsules)IBA 01/2021 - 01/2015
4	Messenger RNA (mRNA)IBA 01/2020 - 11/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 05/2015
4	LigandsIBA 03/2017 - 06/2010
4	DisulfidesIBA 01/2017 - 06/2010
3	AntigensIBA 04/2024 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 01/2019
3	Antineoplastic Agents (Antineoplastics)IBA 10/2022 - 05/2015
3	Polysaccharides (Glycans)IBA 01/2022 - 01/2016
3	naoxintongIBA 01/2021 - 01/2019
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 01/2018
3	naringinIBA 01/2020 - 01/2019
3	tetracarboxyphenylporphineIBA 01/2019 - 09/2016
3	Glutathione (Reduced Glutathione)IBA 01/2019 - 12/2017
3	Transcription Activator-Like EffectorsIBA 03/2018 - 09/2015
2	Glucose OxidaseIBA 03/2024 - 01/2022
2	IonsIBA 03/2024 - 01/2020
2	AlginatesIBA 03/2024 - 11/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 01/2020
2	CholesterolIBA 01/2024 - 11/2014
2	LipidsIBA 01/2024 - 01/2019
2	AntioxidantsIBA 12/2023 - 01/2019
2	PlatinumIBA 01/2023 - 01/2016
2	MetalsIBA 01/2022 - 01/2020
2	Long Noncoding RNAIBA 01/2022 - 04/2018
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2020
2	SolutionsIBA 01/2021 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2015
2	FlavonoidsIBA 01/2020 - 04/2018
2	Photosensitizing Agents (Photosensitizers)IBA 01/2020 - 01/2018
2	CollagenIBA 01/2020 - 09/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2018
2	Anaplastic Lymphoma KinaseIBA 01/2020 - 07/2015
2	RNA (Ribonucleic Acid)IBA 01/2020 - 10/2019
2	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2019 - 03/2018
2	Cell-Penetrating PeptidesIBA 02/2016 - 01/2013
2	AvidinIBA 01/2013 - 06/2010
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 04/2024
1	VNP 20009 (VNP20009)IBA 04/2024
1	PolymersIBA 04/2024
1	OligosaccharidesIBA 04/2024
1	ChitosanIBA 04/2024
1	HydrogelsIBA 03/2024
1	acceleratory factor from growth hormone (AcG)IBA 03/2024
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024
1	oxidized low density lipoproteinIBA 01/2024
1	Triglycerides (Triacylglycerol)IBA 01/2024
1	CurcuminIBA 01/2024
1	LDL CholesterolIBA 01/2024

Therapy/Procedure

42	Therapeutics 03/2024 - 03/2005
8	Drug Therapy (Chemotherapy) 01/2023 - 09/2008
7	Immunotherapy 03/2024 - 01/2018
7	Precision Medicine 01/2021 - 01/2016
6	Photochemotherapy (Photodynamic Therapy) 01/2021 - 12/2017
3	Radiotherapy 01/2023 - 01/2022
3	Photothermal Therapy 01/2022 - 01/2018
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2019 - 04/2018